Reuters logo
BRIEF-Mabvax Therapeutics files IND application for MVT-1075
January 9, 2017 / 1:53 PM / a year ago

BRIEF-Mabvax Therapeutics files IND application for MVT-1075

Jan 9 (Reuters) - Mabvax Therapeutics Holdings Inc

* Mabvax Therapeutics files Investigational New Drug (IND) application for novel radioimmunotherapy agent MVT-1075

* Patient enrollment in trial expected to begin in early 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below